DISEASE/DRUGS PT.1
DISEASE/DRUGS PT 2.
DISEASE/DRUGS PT. 3
DISEASE/DRUGS PT. 4
DISEASE/DRUGS PT. 5
100

This condition, often referred to as "floppy baby syndrome," is characterized by constipation, loss of head control, and flaccid paralysis resulting from the ingestion of toxins that block acetylcholine release at the neuromuscular junction

Botulism 

100

This genetic condition results in high levels of plasma LDL and premature atherosclerosis, often manifesting physically as xanthomas, xanthelasmas, and corneal arcus

Familial Hypercholesterolemia

100

Unlike I-cell disease, this milder condition involves the same gene but different alleles, allowing for residual enzymatic function and survival into adulthood

Pseudo-Hurler Polydystrophy (Mucolipidosis III)

100

This specific mucopolysaccharidosis is the only one in its class that is X-linked rather than autosomal recessive, and it is clinically distinguished from Hurler syndrome by the absence of corneal clouding

Hunter syndrome (MPS II)

100

The most severe form of MPS, known as MPS IH, is caused by a deficiency of α-L-iduronidase, leading to the accumulation of dermatan and heparan sulphate

Hurler syndrome

200

This specific synaptic vesicle protein is the primary target for both botulinum and tetanus toxins; once cleaved, the vesicle cannot fuse with the axonal membrane

Synaptobrevin (v-SNARE)

200

This autosomal recessive disorder involves a defect in β-Hexosaminidase A, resulting in an inability to remove N-acetylneuraminic acid (NANA) from the GM2 ganglioside

Tay-Sachs disease

200

These two drugs are utilized in the treatment of cancers with a high mitotic index because they bind to tubulin subunits and prevent polymerization


DAILY DOUBLE!!!! 

Vincristine & Vinblastine 

200

This nucleoside analogue used in HIV treatment competes with dTTP for viral reverse transcriptase but accidentally inhibits DNA polymerase γ (POLG), leading to mtDNA depletion and acquired myopathy

AZT (Zidovudine)

200

This specific pathology involves a mutation in Keratin 9, an intermediate filament protein that is expressed exclusively in the palms of the hands and the soles of the feet

Epidermolytic Palmoplantar Keratoderma

300

Mutations in the gene encoding this specific nuclear intermediate filament can result in a wide array of serious "laminopathies," including Hutchinson-Gilford Progeria and Emery-Dreifuss muscular dystrophy

Lamin A

300

While one is a fungal derivative and the other is a toxin extracted from "toadstool mushrooms," both of these substances interfere with cellular movement by specifically inhibiting the depolymerization of F-actin filaments


DAILY DOUBLE!!!! 

 Cytochalasins & Phalloidin

300

This congenital syndrome, part of a spectrum of PEX gene mutations, results in "empty" peroxisomes and a total failure to import peroxisomal enzymes

Zellweger syndrome 

300

This bacterial toxin causes debilitating diarrhea by binding specifically to GM1 ganglioside receptors located on the surface of intestinal epithelial cells

Cholera toxin 
300

This autosomal recessive condition is characterized by immotile sperm and cilia, often resulting in infertility and recurrent respiratory infections such as bronchitis and sinusitis. It is caused by disrupted dynein arms within the axoneme

Primary Ciliary Dyskinesia (PCD)

400

This cardiac disease is associated with defects in the intermediate filaments that normally form a protective network around myofibrils at the Z disk to help the cell withstand mechanical stress

Desmin-related myofibrillar myopathy 

400

Unique among mitochondrial diseases because it can be either homoplasmic or heteroplasmic, this condition results in subacute, painless, bilateral central visual failure

Leber's Hereditary Optic Neuropathy (LHON)

400

MELAS is caused by a point mutation in this mitochondrial gene 

tRNA Leucine 

400

Hereditary Spherocytosis is an autosomal dominant condition that stems from mutations in these skeletal membrane proteins 


DAILY DOUBLE!!!!!

Spectrin & Ankyrin 

400

Unlike many other storage diseases, Chédiak-Higashi syndrome is classified as a defect lysosomal: 

Trafficking 

500

This disease while not a direct genetic mutation of a membrane protein, is caused by elevated cholesterol synthesis, which leads to an excess cholesterol in the RBC plasma membrane 

Acanthocytosis (aka Spur cell anemia)

500

While both of these sporadic conditions are caused by giant mtDNA deletions, this pediatric disease is distinguished by bone marrow involvement (pancytopenia) and exocrine pancreatic failure with deletions present in all tissues; in contrast, its late-onset counterpart involves deletions found in muscle but not in blood and is clinically characterized by progressive external ophthalmoplegia, ataxia, and heart block. Notably, children who survive the more severe pediatric form often undergo a "phenotype switch" to the late-onset syndrome 


DAILY DOUBLE!!!

 Pearson syndrome and Kearns-Sayre syndrome (KSS)

500

These intraneuronal structures form during the pathogenesis of Alzheimer’s disease when the microtubule-associated protein Tau becomes hyperphosphorylated, leading to the depolymerization of microtubules and the subsequent disruption of axonal transport

Neurofibrillary Tangles (NFTs)

500

In patients with Zellweger Syndrome, the severe failure to import necessary enzymes into the organelle matrix often occurs because mutant peroxins are unable to recognize this specific C-terminal tripeptide sequence

SKL tag

500

Tay-sachs disease is caused by a deficiency or total absence of the enzyme β-Hexosaminidase A. This enzyme is normally responsible for the degradation of sphingolipids within the lysosome. Specifically, in the sphingolipid degradation pathway, β-Hexosaminidase A is required to remove this particular sugar from the GM2 Ganglioside 

N-acetylneuraminic acid (NANA)

M
e
n
u